Picture of Xenetic Biosciences logo

XBIO — Xenetic Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Xenetic Biosciences Inc expected to post a loss of 11 cents a share - Earnings Preview

* Xenetic Biosciences Inc  XBIO.OQ   XBIO.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 10
(estimated). 
    * The Framingham Massachusetts-based  company is expected to
report  a 5.4% increase in revenue to $410 thousand from $388.99
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Xenetic Biosciences
Inc
is for a loss of 11 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated May 8 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Xenetic Biosciences

See all news